Lyka Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 inter alia to consider and approve 1. To consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the 2nd quarter and six months ended 30th September 2025 alongwith Limited Review Report issued by Statutory Auditor of the Company 2. To consider and approve shifting of the Registered Office of the Company from State of Gujarat to Maharashtra 3. To consider and approve Notice of Extra-Ordinary General Meeting of the Company 4. Any other Business